Peptide mapping of proteins in cerebrospinal fluid utilizing a rapid preparative two-dimensional electrophoretic procedure and matrix-assisted laser desorption/ionization mass spectrometry

Biochimica et Biophysica Acta - General Subjects

Volumn 1473, Issue 2-3, 1999, Pages 391-399

  Davidsson, Pia ^a   Nilsson, Carol L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Electroelution; Liquid phase IEF; Matrix assisted laser desorption ionization mass spectrometry; Peptide mapping; Preparative two dimensional gel electrophoresis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; OROSOMUCOID; TRANSFERRIN;

ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID; HUMAN; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; TWO DIMENSIONAL ELECTROPHORESIS;

CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; ISOELECTRIC FOCUSING; PEPTIDE MAPPING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRYPSIN;

EID: 0032713887     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00197-X     Document Type: Article

References (23)

1. O'Farrell P.H. High resolution two-dimensional electrophoresis. J. Biol. Chem. 250:1975;4007-4021.
2. Harrington M.G., Merril C.R., Torrey E.F. Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons. Clin. Chem. 31:(5):1985;722-726.
3. Harrington M.G., Kennedy P. The clinical use of the cerebrospinal fluid studies in demyelinating neurological diseases. Postgrad. Med. J. 63:(743):1987;735-740.
4. Harrington M.G., Merril C.R. Cerebrospinal fluid protein analysis in diseases of the nervous system. J. Chromatogr. 429:1988;345-358.
5. Merril C.R., Harrington M.G. Use of the two-dimensional electrophoretic protein maps in studies of schizophrenia. Schizophr. Bull. 14:(2):1988;249-254.
6. Klose J., Kobaltz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis. 16:1995;1034-1059.
7. Celis J.E., Gromov P., Ostergaard M., Madsen P., Honore B., Dejgaard K., Olsen E., Vorum H., Kristensen D.B., Gromova I., Haunso A., Damme J.V., Puype M., Vandekerckhove J., Rasmussen H.H. Human 2-D PAGE databases for proteome analysis in health and disease: http://biobase.dk/cgi-bin/celis. FEBS Lett. 398:1996;129-134.
8. Yan J.X., Tonella L., Sanchez J.-C., Wilkins M.R., Packer N.H., Gooley A.A., Hochstrasser D.F., Williams K.L. The dictyostelium discoideum proteome-the SWISS-2DPAGE database of the multicellular aggregate (slug). Electrophoresis. 18:1997;491-497.
9. Matsui N.M., Smith D.M., Closer K.R., Fichmann J., Andrews L.E., Sullivan C.M., Burlingame A.L., Epstein L.B. Immobilized pH gradient two-dimensional gel electrophoresis and mass spectrometric identification of cytokine-regulated proteins in ME-180 cervical carcinoma cells. Electrophoresis. 18:1997;409-417.
10. Li G., Waltman M., Anderson N.L., Unsworth E., Treston A., Weinstein J.N. Rapid mass spectrometric identification of proteins from two-dimensional polyacrylamide gels after in gel proteolytic digestion. Electrophoresis. 18:1997;391-402.
11. Davidsson P., Westman A., Puchades M., Nilsson C.L., Blennow K. Characterization of proteins from human cerebrospinal fluid by a combination of preparative two-dimensional liquid phase electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 71:1999;642-647.
12. Nilsson C.L., Puchades M., Westman A., Blennow K., Davidsson P. Identification of proteins in a human pleural exudate using two-dimensional preparative liquid phase electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Electrophoresis. 20:1999;860-865.
13. Peter J., Unverzagt C., Engel W.D., Renaauer D., Seidel C., Hösel W. Identification of carbohydrate deficient transferrin isoforms by MALDI-TOF mass spectrometry and lectin-ELISA. Biochim. Biophys. Acta. 1380:1998;93-101.
14. Davidsson P., Puchades M., Blennow K. Identification of synaptic vesicle, pre- and postsynaptic proteins in human cerebrospinal fluid using liquid phase isoelectric focusing. Electrophoresis. 20:1999;431-437.
15. Roheim P.S., Carey M., Forte T., Vega G.L. Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA. 76:1979;4646-4649.
16. Landen M., Hesse C., Fredman P., Regland B., Wallin A., Blennow K. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without correlation to the apoE4 isoform. Dementia. 7:1996;273-278.
17. Lindh M., Blomberg M., Jensen M., Basun H., Lannfeldt L., Engvall B., Scharnagel H., Marz W., Wahlund L.O., Cowburn R.F. Cerebrospinal fluid apolipoprotein E (ApoE) levels in Alzheimer's disease patients are increased at follow-up and show a correlation with levels of tau protein. Neurosci. Lett. 229:1997;85-88.
18. Hahne S., Nordstedt C., Ahlin A., Nyback H. Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls. Neurosci. Lett. 224:1997;99-102.
19. Song H., Seishima M., Saito K., Maeda S., Takemura M., Norna A., Kondo A., Manabe M., Urakami K., Nakashima K. Apo A-1 and Apo E concentration in cerebrospinal fluids of patients with acute meningitis. Ann. Clin. Biochem. 35:1998;408-414.
20. Jaeken J., van Eijk H.G., Van der Heul C., Corbeel L., Eeckels R., Eggermont E. Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly genetic syndrome. Clin. Chem. Acta. 144:1984;245-247.
21. De Jong G., Feelders R., van Noort W.L., van Eijk H.G. Transferrin microheterogeneity as a probe in normal and disease states. Glycoconj. J. 12:1995;219-226.
22. Vrethem M., Öhman S., Von Schenck H., Forsberg P., Olsson J.-E. Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseases. Acta Neurol. Scand. 75:1987;328-331.
23. Saso L., Leone M.G., Sorrentino C., Giacombelli S., Silverstrini B., Grima J., Li J., Samy E., Mruk D., Cheng C.Y. Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor. Biochemistry. 46:(4):1998;643-655.